23.68 - 23.68
20.75 - 25.07
1.4K / 5.9K (Avg.)
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
36.45%
Revenue growth exceeding 1.5x Insurance - Life median of 0.63%. Joel Greenblatt would verify if operating margins keep pace with this top-line surge.
36.45%
Gross profit growth exceeding 1.5x Insurance - Life median of 0.63%. Joel Greenblatt would check if cost advantages or brand equity drive this surge.
-221.53%
Negative EBIT growth while Insurance - Life median is -5.99%. Seth Klarman would check if external or internal factors caused the decline.
-221.53%
Negative operating income growth while Insurance - Life median is -3.54%. Seth Klarman would check if structural or cyclical issues are at play.
-242.68%
Negative net income growth while Insurance - Life median is 2.89%. Seth Klarman would investigate factors dragging net income down.
-242.69%
Negative EPS growth while Insurance - Life median is 6.56%. Seth Klarman would explore whether share dilution or profit declines are to blame.
-242.69%
Negative diluted EPS growth while Insurance - Life median is 7.09%. Seth Klarman would look for the cause: weakened profitability or heavier share issuance.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
11.68%
OCF growth near Insurance - Life median of 11.68%. Charlie Munger might attribute it to typical sector or cyclical patterns.
11.68%
FCF growth near Insurance - Life median of 11.68%. Charlie Munger could consider this standard for the industry’s capex cycle.
53.41%
10Y revenue/share CAGR exceeding 1.5x Insurance - Life median of 18.82%. Joel Greenblatt would verify if a unique moat or brand fosters outperformance over a decade.
128.29%
5Y revenue/share growth exceeding 1.5x Insurance - Life median of 27.63%. Joel Greenblatt would see if the company’s moat drives rapid mid-term expansion.
0.62%
3Y revenue/share growth below 50% of Insurance - Life median of 2.22%. Jim Chanos would suspect a significant short-term erosion in competitiveness.
117.41%
OCF/share CAGR exceeding 1.5x Insurance - Life median of 28.96% over 10 years. Joel Greenblatt would verify if a unique competitive moat underlies these cash flows.
140.11%
OCF/share CAGR of 140.11% while Insurance - Life median is zero. Walter Schloss might see a slight advantage that can compound if momentum builds.
111.79%
3Y OCF/share growth of 111.79% while Insurance - Life median is zero. Walter Schloss might see a modest advantage that could compound if momentum holds.
-262.93%
Negative 10Y net income/share CAGR vs. Insurance - Life median of 4.74%. Seth Klarman might see a fundamental problem if peers maintain growth.
-262.02%
Negative 5Y CAGR while Insurance - Life median is 25.15%. Seth Klarman might see a specific weakness if peers maintain profitable expansions.
-349.29%
Negative 3Y CAGR while Insurance - Life median is 20.71%. Seth Klarman might see a pressing concern if the rest of the sector is stable or growing.
69.44%
Equity/share CAGR exceeding 1.5x Insurance - Life median of 33.44% over 10 years. Joel Greenblatt would see if a high ROE underlies this compounding advantage.
61.10%
5Y equity/share CAGR 1.25-1.5x Insurance - Life median. Mohnish Pabrai might see disciplined retention of earnings behind outperformance.
23.23%
3Y equity/share CAGR 1.25-1.5x Insurance - Life median. Mohnish Pabrai credits disciplined capital allocation for short-term outperformance.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
8.82%
AR growth of 8.82% while Insurance - Life median is zero. Walter Schloss checks if the difference points to new credit strategy or stronger sales push.
No Data
No Data available this quarter, please select a different quarter.
2.26%
Asset growth exceeding 1.5x Insurance - Life median of 0.81%. Joel Greenblatt confirms strong expansions matched by adequate returns on those assets.
-3.64%
Negative BV/share change while Insurance - Life median is 1.82%. Seth Klarman sees a firm-specific weakness if peers accumulate net worth.
-0.70%
Debt is shrinking while Insurance - Life median is rising. Seth Klarman might see an advantage if growth remains possible.
No Data
No Data available this quarter, please select a different quarter.
8.53%
SG&A growth far above Insurance - Life median. Jim Chanos sees potential red flags in cost management or diminishing returns on spending.